Evonik stock: At EUR 21.59, Evonik stock sits 1.14 percent below its 52-week high

Published on 10/16/2026 at 17:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Parmantier & Cie. set a EUR 20.50 target on October 6, 2026. Evonik stock costs EUR 21.59 on October 16, 2026, up 1.27 percent versus the Xetra close.

Stock sits 1.14 percent below high

On October 16, 2026, Evonik stock traded 1.14 percent below its 52-week high.
Parmantier & Cie. set a EUR 20.50 target on October 6, 2026.
Evonik stock costs EUR 21.59 at Lang & Schwarz on October 16, 2026 at 5:13 p.m. CEST, plus 1.27 percent versus the Xetra close of October 15, 2026, 1.14 percent below the 52-week high of EUR 21.84.
Evonik's next quarterly statement is scheduled for November 3, 2026.

Aquarellmalerei der Essener Skyline mit Villa Hügel und Industriesilhouetten am Baldeneysee — Evonik Industries DE000EVNK013 als Aquarellmalerei der Essener Stadtlandschaft mit Industriesilhouette am Baldeneysee, Illustration mit AI erstellt.

Evonik stock (ISIN DE000EVNK013) was trading at EUR 21.59 at Lang & Schwarz on October 16, 2026 at 5:13 p.m. CEST, 1.14 percent below its 52-week high of EUR 21.84. The price was up 1.27 percent versus the Xetra close of October 15, 2026 at EUR 21.32.

Analyst target stays below price

On October 6, 2026, Parmantier & Cie. set a Hold rating and a six-month price target of EUR 20.50 for Evonik. The target was 5.32 percent below the Lang & Schwarz price. The research house described its report as a study of the European chemicals cycle and listed Evonik alongside Lanxess and Wacker Chemie. The target and rating were published by EQS News.

Second-quarter earnings rose 24.00 percent

Evonik's adjusted EBITDA rose 24.00 percent year over year to EUR 630 million in the second quarter of 2026. The increase reflected higher volumes and prices, which each contributed 7.00 percent, while inventory revaluation effects supported earnings and higher bonus provisions had an adverse effect. These figures and management's upgraded outlook were discussed in the second-quarter call published by Yahoo Finance on August 4, 2026.

Price remains near yearly high

The 52-week range is EUR 12.49 to EUR 21.84. At EUR 21.59, the stock sat 1.14 percent below the upper end of that range. Trading volume was 277,975 shares, compared with an average of 1,314,764 shares. The price therefore remained close to the annual high while turnover was below its average level.

Valuation and November 3 date

Evonik had a market capitalization of EUR 10.1 billion and a P/E ratio of 83.53 as of October 16, 2026. The investor-relations calendar lists November 3, 2026, for publication of the third-quarter statement, according to Evonik.

Comparison with peers

Evonik (Lang & Schwarz, EUR): plus 1.27 percent, P/E 83.53, market capitalization EUR 10.1 billion
Lanxess (Xetra, EUR): plus 5.30 percent, market capitalization EUR 1.2 billion
Wacker Chemie (Xetra, EUR): plus 0.62 percent, market capitalization EUR 4.4 billion

Price position after the Xetra close

Evonik was trading at EUR 21.59 at Lang & Schwarz on October 16, 2026 at 5:13 p.m. CEST, plus 1.27 percent versus the Xetra close of October 15, 2026 at EUR 21.32. The further course of trading is shown by the continuously updated real-time quote of Evonik stock.